2009 Report posted for filing   Reviewed by John M. Grohol, Psy.D. on June 14, 2009 Eli Lilly & Co.’s atypical antipsychotic medication, Zyprexa, was not only marketed to doctors for an unapproved, off-label use — the treatment of dementia… Read More ›